Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 3/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 9/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | F2R | P25116 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7447050 | 0.92 | ITGB3 (0.42) | CHRM1ITGB3ITGA2BALDH1A1MEN1 | |
| SCHEMBL7437367 | 0.91 | ITGB3 (0.41) | CHRM1ITGB3ITGA2BALDH1A1MEN1 | |
| SCHEMBL7446169 | 0.89 | ITGB3 (0.51) | ITGB3ITGA2BF2R | |
| SCHEMBL7290589 | 0.87 | CHRM1 (0.51) | CHRM1ITGB3ITGA2BALDH1A1GAA | |
| SCHEMBL7449634 | 0.87 | ALDH1A1 (0.40) | CHRM1HTTALDH1A1GAAMEN1 | |
| SCHEMBL7449642 | 0.86 | CHRM1 (0.40) | CHRM1ITGB3ITGA2BHTTALDH1A1 | |
| SCHEMBL7452172 | 0.84 | ITGB3 (0.51) | CHRM1ITGB3ITGA2BHTTALDH1A1 | |
| SCHEMBL7446868 | 0.84 | ALDH1A1 (0.40) | CHRM1ITGB3ITGA2BHTTALDH1A1 | |
| SCHEMBL7506228 | 0.84 | ITGB3 (0.57) | CHRM1ITGB3ITGA2BF2R | |
| SCHEMBL7441377 | 0.83 | ITGB3 (0.38) | ITGB3ITGA2BHTTALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384028-B1 | TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| EP-0869944-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| WO-1996029309-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-26 | — | — | WO | disclosed |